$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
Health Care Stocks Could Use A Surgical Boom — Will It Happen For Stryker, Boston Scientific, Others?
12:00pm, Tuesday, 15'th Mar 2022 Investor''s Business Daily
The post-Covid recovery in elective procedures is far from certain. But if it materializes, it could stoke some health care stocks.
Boston Scientific: Weak M&A Strategy Weighing Down Price Target
05:44am, Monday, 14'th Mar 2022 Seeking AlphaBoston Scientific: Weak M&A Strategy Weighing Down Price Target
01:44am, Monday, 14'th Mar 2022
Boston Scientific's M&A strategy has led to decreasing ROI from its acquisitions over the past 5 years from 5.97% in 2017 to 1.09% in 2021.
Trading The Top 10 Stocks From 40 Large Hedge Funds: Trading Update 3/12/2022
07:12am, Sunday, 13'th Mar 2022 Seeking Alpha
Strategy of selecting 10 of 50 stocks, equally weighted, would have increased total return to 188.6%. Here we report most recent holdings and trading signals for 3/14/2021.
Read This First Before You Buy Boston Scientific Corporation (NYSE: BSX) Stock
06:00pm, Friday, 11'th Mar 2022 Stocks Register
Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Friday, March 11, with the stock price up by 0.96% to the previous day’s close as strong demand from buyers drove the stock to $42.14. Actively observing the price movement in the recent trading, the stock is buoying the session at $41.74, falling within a range … Read This First Before You Buy Boston Scientific Corporation (NYSE: BSX) Stock Read More »
The "Carotid and Renal Artery Stents (Cardiovascular) - Global Market Analysis and Forecast Model" report has been added to ResearchAndMarkets.com''s offering. Carotid and Renal Artery Stents (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Carotid and Renal Artery Stents market for the year 2020 and beyond. Three types of therapies are recommended for carotid stenosis. These therapies include medication, endovascular intervention, and endarterectomy. Endarterectomy is recommended over stenting to patients who are suffering from stenosis (>70%) and have had symptoms for the last six months to a year. It is not recommended to individuals with 50% or less stenosis in the carotid artery. Endovascular therapy is … Full story available on Benzinga.com
released a new market study on 2022-2028 Interventional Oncology Ablation Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The global research report delivers an in-depth
IHI: A Standout Performer With Equally Strong Future Growth Prospects
05:42am, Saturday, 05'th Mar 2022 Kwhen FinanceIHI: A Standout Performer With Equally Strong Future Growth Prospects
12:42am, Saturday, 05'th Mar 2022
IHI: A Standout Performer With Equally Strong Future Growth Prospects
Boston Scientific (BSX) Up 3.2% Since Last Earnings Report: Can It Continue?
04:31pm, Friday, 04'th Mar 2022 Zacks Investment Research
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Boston Scientific finance subsidiary prices €3B of senior notes (NYSE:BSX)
11:46am, Friday, 04'th Mar 2022 Seeking Alpha
American Medical Systems Europe, a wholly-owned finance subsidiary of Boston Scientific (BSX), has priced a public offering of €3B of senior notes.The offering comprises €1B…
Boston Scientific begins tender offer for up to $2.5B debt securities
10:32am, Wednesday, 02'nd Mar 2022 Seeking Alpha
Sundry Photography/iStock Editorial via Getty Images Boston Scientific (NYSE:BSX) began a cash tender offer for up to $2.5B principal amount of certain outstanding senior notes.Holders of…
Hopeful Golden Cross Forms On Boston Scientific''s Chart
02:51pm, Tuesday, 01'st Mar 2022 Benzinga
If history is any guide, there may be good fortune ahead for shares of Boston Scientific (NYSE: BSX ). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions. When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses below the long-term … Full story available on Benzinga.com
Global Drug-Device Combinations Markets Report 2022: Data from 2020, Estimates from 2021, & CAGR Projections Through 2026 - ResearchAndMarkets.com
11:13am, Tuesday, 01'st Mar 2022 Kwhen Finance
New York, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Minimally Invasive Surgical Systems Market: Focus on Product Type, Application, End Users, 25 Countries'' Data, Patent Scenario, and Competitive Landscape - Analysis and Forecast, 2021-2031" - https://www.reportlinker.com/p06135349/?utm_source=GNW Market Segmentation • Product - Conventional Technologies (Endoscopes and Endoscopic Systems, Video and Visualization Systems, Capsule Endoscopy, Instruments and Accessories, Others), Surgical Robotics (Robotic Systems, Instruments and Accessories, Services) • Application - General Surgery, Urology Surgery, Gynecology Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery, Others • End User - Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics • Region - North America, Europe, Asia-Pacific, Latin America, Middle East and Africa Regional Segmentation • North America - U.S., Canada • Europe - Germany, France, Spain, U.
Sign In
Buy BSX